Radiotherapy for Lung Cancer can be dangerous: Study supriya kashyap kashyap3 May 2016 12:28 PM ISTA type of radiotherapy called stereotactic body radiation therapy (SBRT) can put patients with early stage non-small cell lung cancer (NSCLC) at an...
Adjuvant chemotherapy improves overall survival in patients with stage IB non-small cell lung cancer supriya kashyap kashyap14 Jun 2016 1:25 PM ISTDenver : The use of adjuvant chemotherapy in early-stage non small cell lung cancer (NSCLC) patients improves overall survival (OS) and 5-year OS in...
Osimertinib in lung cancer: added benefit not proven supriya kashyap kashyap22 Jun 2016 2:55 PM ISTOsimertinib has been approved since February 2016 for the treatment of adult patients with locally advanced or metastatic epidermal growth factor...
Pembrolizumab new option for first line treatment of patients with advanced lung cancer and high PD-L1 expression supriya kashyap kashyap11 Oct 2016 12:50 PM ISTPembrolizumab is set to become a new option for first line treatment of patients with advanced lung cancer and high PD-L1 expression, according to the...
New immunotherapy Combo has promising results in lung cancer Anjali Nimesh Nimesh8 April 2018 7:05 PM ISTNon-small cell lung cancer is the most common form of lung cancer.Patients with metastatic non-small cell lung cancer will always progress after...
High BMI may improve survival among patients with certain cancers: JAMA Hina Zahid27 Dec 2019 8:20 PM ISTHigh body mass index (BMI) is independently associated with overall survival benefit from immune checkpoint inhibitor therapy in patients with...
Combination therapy doubles survival in metastatic lung cancer Anjali Nimesh Nimesh19 May 2018 7:05 PM ISTThe immunotherapy drug pembrolizumab, when combined with chemotherapy, doubles survival in patients with non-squamous non-small cell lung cancer...
FDA approves imfinzi (durvalumab) for unresectable stage III non-small cell lung cancer Anjali Nimesh Nimesh18 Feb 2018 7:20 PM ISTUS Food and Drug Administration (FDA) has approved IMFINZI® (durvalumab) for the treatment of patients with unresectable Stage III non-small cell lung...
Bronchial carcinoma: Added benefit of crizotinib not proven supriya kashyap kashyap12 Jan 2017 12:29 PM ISTSince August 2016 crizotinib (trade name: Xalkori) has also been available for adults with advanced non-small cell lung cancer (NSCLC) in whom the...
Researchers Inhibit Tumor Growth in New Subtype of Lung Cancer supriya kashyap kashyap4 Aug 2016 2:13 PM ISTBoston : Lung cancer is the most common cause of cancer deaths, accounting for about a third of all tumor related deaths. Adenocarcinomas, a non small...
